The Impact of COVID-19 is included in Uterine Fibroid Treatment Device Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Uterine Fibroid Treatment Device Trends and Forecast
The future of the global uterine fibroid treatment device market looks promising with opportunities in the invasive, minimally invasive, and non-invasive markets. The global uterine fibroid treatment device market is expected to reach an estimated $8.8 billion by 2030 with a CAGR of 8.4% from 2024 to 2030. The major drivers for this market are growing number of uterine fibroid patients and increasing demand for minimally invasive and non-invasive procedures to treat uterine fibroids.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Uterine Fibroid Treatment Device by Segment
The study includes a forecast for the global uterine fibroid treatment device by technology, mode of treatment, and region.
Uterine Fibroid Treatment Device Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
• Surgical
• Ablation
Uterine Fibroid Treatment Device Market by Mode of Treatment [Shipment Analysis by Value from 2018 to 2030]:
• Invasive
• Minimally Invasive
• Non-Invasive
Uterine Fibroid Treatment Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Uterine Fibroid Treatment Device Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies uterine fibroid treatment device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the uterine fibroid treatment device companies profiled in this report include-
• Medtronic
• Stryker
• CooperSurgical
• Ethicon
• Hologic
• Minerva Surgical
• Lumenis
Uterine Fibroid Treatment Device Market Insights
Lucintel forecasts that surgical will remain the larger segment over the forecast period due to rising number of hysterectomy and myomectomy surgical procedures.
Within this market, invasive will remain the largest segment due to rising cases of uterine fibroids and associated symptoms in women.
North America will remain the largest segment over the forecast period due to existence of well-established healthcare facilities and growing government initiatives in the region.
Features of the Global Uterine Fibroid Treatment Device Market
Market Size Estimates: Uterine fibroid treatment device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Uterine fibroid treatment device market size by technology, mode of treatment, and region in terms of value ($B).
Regional Analysis: Uterine fibroid treatment device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technologies, mode of treatment, and regions for the uterine fibroid treatment device market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the uterine fibroid treatment device market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the uterine fibroid treatment device market size?
Answer: The global uterine fibroid treatment device market is expected to reach an estimated $8.8 billion by 2030.
Q2. What is the growth forecast for uterine fibroid treatment device market?
Answer: The global uterine fibroid treatment device market is expected to grow with a CAGR of 8.4% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the uterine fibroid treatment device market?
Answer: The major drivers for this market are growing number of uterine fibroid patients and increasing demand for minimally invasive and non-invasive procedures to treat uterine fibroids.
Q4. What are the major segments for uterine fibroid treatment device market?
Answer: The future of the uterine fibroid treatment device market looks promising with opportunities in the invasive, minimally invasive, and non-invasive markets.
Q5. Who are the key uterine fibroid treatment device market companies?
Answer: Some of the key uterine fibroid treatment device companies are as follows:
• Medtronic
• Stryker
• CooperSurgical
• Ethicon
• Hologic
• Minerva Surgical
• Lumenis
Q6. Which uterine fibroid treatment device market segment will be the largest in future?
Answer: Lucintel forecasts that surgical will remain the larger segment over the forecast period due to rising number of hysterectomy and myomectomy surgical procedures.
Q7. In uterine fibroid treatment device market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest segment over the forecast period due to existence of well-established healthcare facilities and growing government initiatives in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the uterine fibroid treatment device market by technology (surgical and ablation), mode of treatment (invasive, minimally invasive, and non-invasive), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Uterine Fibroid Treatment Device Market, Uterine Fibroid Treatment Device Market Size, Uterine Fibroid Treatment Device Market Growth, Uterine Fibroid Treatment Device Market Analysis, Uterine Fibroid Treatment Device Market Report, Uterine Fibroid Treatment Device Market Share, Uterine Fibroid Treatment Device Market Trends, Uterine Fibroid Treatment Device Market Forecast, Uterine Fibroid Treatment Device Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Uterine Fibroid Treatment Device Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Uterine Fibroid Treatment Device Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Uterine Fibroid Treatment Device Market by Technology
3.3.1: Surgical
3.3.2: Ablation
3.4: Global Uterine Fibroid Treatment Device Market by Mode of Treatment
3.4.1: Invasive
3.4.2: Minimally Invasive
3.4.3: Non-Invasive
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Uterine Fibroid Treatment Device Market by Region
4.2: North American Uterine Fibroid Treatment Device Market
4.2.2: North American Uterine Fibroid Treatment Device Market by Mode of Treatment: Invasive, Minimally Invasive, and Non-Invasive
4.3: European Uterine Fibroid Treatment Device Market
4.3.1: European Uterine Fibroid Treatment Device Market by Technology: Surgical and Ablation
4.3.2: European Uterine Fibroid Treatment Device Market by Mode of Treatment: Invasive, Minimally Invasive, and Non-Invasive
4.4: APAC Uterine Fibroid Treatment Device Market
4.4.1: APAC Uterine Fibroid Treatment Device Market by Technology: Surgical and Ablation
4.4.2: APAC Uterine Fibroid Treatment Device Market by Mode of Treatment: Invasive, Minimally Invasive, and Non-Invasive
4.5: ROW Uterine Fibroid Treatment Device Market
4.5.1: ROW Uterine Fibroid Treatment Device Market by Technology: Surgical and Ablation
4.5.2: ROW Uterine Fibroid Treatment Device Market by Mode of Treatment: Invasive, Minimally Invasive, and Non-Invasive
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Uterine Fibroid Treatment Device Market by Technology
6.1.2: Growth Opportunities for the Global Uterine Fibroid Treatment Device Market by Mode of Treatment
6.1.3: Growth Opportunities for the Global Uterine Fibroid Treatment Device Market by Region
6.2: Emerging Trends in the Global Uterine Fibroid Treatment Device Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Uterine Fibroid Treatment Device Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Uterine Fibroid Treatment Device Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Medtronic
7.2: Stryker
7.3: CooperSurgical
7.4: Ethicon
7.5: Hologic
7.6: Minerva Surgical
7.7: Lumenis
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Uterine Fibroid Treatment Device Market Report.